Delivery Order SPE2DR25D2006-SPE2DR26F56EQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,437.12 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 8, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This is a competitive award with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,098.45 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.65 to AmerisourceBergen Drug Corp for the provision of Varivax vaccine with diluents. The contract, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,994.60 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order valued at $4,997.30 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and supply the vaccine products to support federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56EQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,997.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award to a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and related medical commodities. The company's federal contract portfolio demonstrates extensive experience fulfilling vaccine procurement requirements and other critical medical supply needs across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/20/25 |